MiMedx signs definitive agreement to acquire Stability Biologics

January 11, 2016 12:46 AM

28 0

NEW YORK MiMedx Group Inc finalized a deal Sunday to acquire Stability Biologics for $10 million in cash and stock.

The regenerative medicine company MiMedx said the acquisition of Stability Biologics, a provider of human tissue and bone graft products, adds a new sales channel and roughly 100 salespeople to the company.

Also read: Record 47 million expected to travel for U.S. July Fourth holiday: AAA

Read more

To category page